Your session is about to expire
← Back to Search
Device
Accuryn Monitoring System for Acute Kidney Injury
N/A
Recruiting
Research Sponsored by Potrero Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Summary
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
Eligible Conditions
- Acute Kidney Injury
- Cardiac Surgery
- Abdominal Compartment Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abdominal Compartment Syndrome (ACS)
Kidney
Intra-Abdominal Pressure (IAP)
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Accuryn Monitoring SystemExperimental Treatment1 Intervention
Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Accuryn Monitoring System
2017
N/A
~50
Find a Location
Who is running the clinical trial?
Potrero MedicalLead Sponsor
7 Previous Clinical Trials
183 Total Patients Enrolled
3 Trials studying Acute Kidney Injury
62 Patients Enrolled for Acute Kidney Injury
Vanessa Moll, MD, PhDStudy DirectorPotrero Medical
Share this study with friends
Copy Link
Messenger